A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer
Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
Chloroquine (CQ) is a well known, well tolerated medication that has been used for many years
traditionally for arthritis, lupus, and malaria. It has anti-inflammatory properties but is
often the drug of choice for arthritis and malaria due to its few side effects. Recently,
laboratory investigations have proven that CQ may potentially have anti-cancer properties, by
inhibiting a process which allows cancers such as breast cancer to continue to grow (a
process known as "autophagy"). Therefore, this study will look at how well CQ can inhibit the
growth of breast cancers in patients while waiting for surgery.